QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 this-cannabinoids-focused-pharma-co-sees-50-yoy-surge-in-revenue-in-2023-trims-losses

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday i...

 canadian-cbd-focused-pharma-co-gets-green-light-to-produce-medical-marijuana-in-brazil

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for...

 key-leadership-changes-in-cannabis-you-should-know-about-as-we-head-into-2024

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing tog...

 medipharm-labs-still-hits-c85m-despite-sequential-drop-more-on-that-in-q3-2023-financial-report

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September ...

 new-cannabis-products-energize-global-health--wellness-market-including-australia

In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness ...

 medipharm-settles-commercial-agreement-dispute-with-tilrays-hexo-for-9m

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve...

 new-cbd--thc-cannabis-oils-now-shipping-to-australia-from-canada

MediPharm Labs Corp.

 medipharm-labs-breaks-free-from-royalty-agreement-what-it-means--whats-next

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreeme...

 could-medical-cannabis-be-the-answer-for-fibromyalgia-heres-what-new-study-found

New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxi...

 cannabinoid-focused-pharma-stock-slides-on-q2-earnings-report-here-are-the-details

Cannabinoid-focused pharmaceutical company MediPharm Labs Corp.

 medipharm-delivers-cannabis-clinical-trial-material-to-us-research-partner-and-provides-update-on-fda-status

MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed th...

 leadership-shake-ups-across-several-weed-companies-who-got-the-top-jobs

As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors ...

 medipharm-labs-corp-q1-revenue-grows-20-yoy-achieves-first-quarter-of-positive-adjusted-ebitda

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth ove...

 medipharm-labs-begins-restructuring-following-acquisition-of-vivo-reduces-non-direct-labor-workforce-by-30

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabi...

 medipharm-labs-fy22-revenue-grows-slightly-to-163m

MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1....

 medipharm-labs-shareholders-approve-merger-with-vivo-cannabis

MediPharm Labs Corp.

 historic-ruling-to-legalize-cannabis-cultivation-in-brazil-these-weed-companies-will-likely-benefit

Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian ap...

 medipharm-labs-to-acquire-vivo-cannabis

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc.

 medipharm-touts-strong-q3-revenue-growth-continues-to-expand-internationally

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION